#dmpk studies

[cdmoservices]

How does PAMPA assay help in the assessment of bioavailability of the drug molecules? How does it determine the drug absorption of the drug molecule?

Parallel Artificial Membrane Permeability (PAMPA) assay evaluates the potency of the drug candidates in the early drug development methods. Permeability is a physicochemical property which helps in the assessment of pharmacokinetic gastrointestinal absorption, blood brain permeability, and transdermal penetration. It also governs the availability of drugs in the body systems and their active/ passive absorptions. It is energy independent and helps in determining the passive diffusion in drug absorption and avoids any complexities based on active transport of drug compounds.

 BIOAVAILABILITY ASSESSMENT AND DRUG ABSORPTION:

Drug absorption forms the main criteria in determining the potential of active pharmaceutical ingredients in the early stage of drug development. To know whether the drug concentration is reaching the sufficient physiological level the solubility and permeability of the oral drugs in the gastrointestinal system is evaluated.

For the bioavailability and drug absorption of the drug molecule to have a good therapeutic effect, it is required to penetrate through the blood brain barrier. It helps in passive transcellular permeation and diffusion of drugs. It is an effective screening tool to validate the passive transport of potential drug candidates across blood barriers. The main advantage of PAMPA assay in determining the bioavailability of the drug candidate is that it is a quick, highly reliable, and cost effective method and also gives high productivity and versatility. The PAMPA assay data when collaborated with cell membrane permeability assays can give information regarding design and structural modifications of the drug compounds.

PAMPA assay is the most commonly used viable technique carried out in a polar brain lipid membrane which involves non cell based in vitro assay with 96 well plates. A hydrophobic filter coated with lipid membrane is used which allows the drug compound to pass through from the donor zone to the acceptor zone through the membrane filter. After the incubation period at room temperature, the concentrations are measured in either compartments. The solubilizing and binding agents in the donor zone combine with the drug to ease its permeability. Based on the studies of the active transport and passive diffusion of drugs the assay can determine the bioavailability of the drug molecule. This helps in giving reproducible and consistent data with precision on the bioavailability and passive absorption of the drug candidate.

This assay has the ability to study and validate the permeability over a wide pH range across the gastrointestinal tract. It is to understand the absorption of the oral drug molecule and it helps in determining the absorption kinetic parameters and oral absorption efficiency of many formulation drugs.

To account for the analytical variability and increase in the performance of the assays, the permeability of drugs is studied involving variations in lipid volume, lipid application timing and drug infusion. Also, the system is formatted with biomimetic design to increase the permeability performance with reference to lipid, pH, and chemical composition.

[cdmoservices]

Aurigene Pharmaceutical Services offers a wide range of services in the area of in-vitro and/or in-vivo ADME studies - DMPK studies. With decades of experience, our dedicated team of DMPK - ADME scientists have provided innovative solutions to major pharma and biotech companies globally.

Learn More - https://www.aurigeneservices.com/discovery-biology-services/adme-dmpk-studies

[cdmoservices]

How does DMPK help in drug profiling and drug safety of the new drug  entity

DMPK studies helps in the understanding of pharmacokinetic properties of the drug compound to validate and assess the drug safety and profile of the drug compound. This helps in the drug development process to evaluate and understand how the drug  is cleared  from  the  body  after being administered into the body without producing toxic metabolites or showing adverse side effects. DMPK analysis is done throughout the drug discovery phases. 

How does it help in drug profiling and safety  of new drug molecules?

DMPK studies involve process optimization techniques that require experimental validation of data involving solubility, permeability, metabolism and drug to drug interactions that can affect the safety and efficacy of the new drug entity. It mainly involves the  Absorption, Distribution, Metabolism and Excretion (ADME) analysis of the drug compound. ADME studies are carried out with in vitro and in vivo methods.

In vitro models account for the ADME parameters that involve study of permeability, metabolic stability, phenotyping, protein binding technique, drug to drug interaction potentials, cell proliferation and cytotoxicity.

It helps in assessing the factors like bioavailability and drug–drug interactions (DDI) and validates the properties like clearance, half-life, distribution volume and metabolic profile.

DMPK studies provide structural transformation by understanding its pharmacokinetic properties. Validating and studying the nature of drug enzymes, transporters, inhibitors and induction would reduce the potential DDI which in turn would reduce the attrition for the safety profiles and efficacy of the drug.

Pharmacokinetic and blood brain barrier studies give interpretation for preclinical toxicological data and efficacy. Also, the studies give the understanding of mechanisms of drug activities and optimization in drug discovery methods. It also helps in the assessment of dosage, design module and clinical advantages and procedures.

Drug metabolizing enzymes and transporters play a vital role in understanding the regulatory mechanisms governed in the studies. Nuclear receptors and non-coding RNAs that  form a part of transcriptional and post transcriptional factors decide the modulation of DMPK studies. The drug metabolism and bioanalysis studies give the proper estimation of DDI, toxicological results and therapeutic indices through the assessment of in vitro and in vivo pharmacokinetic studies. Pharmacological assessment is necessary for the lead optimization during the drug development process to elucidate the structure activity relationships (SAR) and structure property relationships (SPR). The pharmacokinetic properties verify the ADME datas regarding the drugs bioavailability and short half-life.

The good DMPK profile reduces the risk factors associated with drug delivery systems. Sometimes the oral administration can result in poor absorption and bioavailability and hence a poor DMPK profile can decrease the therapeutic efficacy of the drug.

Drug development and discovery methods have been improved over the years by using the latest techniques and tools used for the evaluation of the DMPK properties and studies. For the process optimization techniques, DMPK properties have been formatted, improved and applied in the drug delivery and development strategy to affect the development strategy.

[cdmoservices]

The Role of DMPK Studies in Drug Discovery

Learn More - https://www.aurigeneservices.com/blog/the-role-of-dmpk-studies-in-drug-discovery

[cdmoservices]

DMPK studies play a crucial role in drug discovery for optimizing the drug-like properties of compounds or drug molecules. They enable researchers to rank compounds based on favorable pharmacokinetic properties associated with absorption, distribution, clearance, elimination (ADME) and DDI potential.